Nature Review Cardiology: Roadmap for alleviating the manifestations of ageing in the cardiovascular system 

Nature Review Cardiology: Roadmap for alleviating the manifestations of ageing in the cardiovascular system 

Ageing of the cardiovascular system is associated with frailty and various life-threatening diseases. As global populations grow older, age-related conditions increasingly determine healthspan and lifespan. The circulatory system not only supplies nutrients and oxygen to all tissues of the human body and removes by-products but also builds the largest interorgan communication network, thereby serving as a gatekeeper for healthy ageing. Therefore, elucidating organ-specific and cell-specific ageing mechanisms that compromise circulatory system functions could have the potential to prevent or ameliorate age-related cardiovascular diseases. In support of this concept, emerging evidence suggests that targeting the circulatory system might restore organ function.

A large consortium of aging scientists from around the world recently published a Roadmap article in Nature Review Cardiology delving into the organ-specific and cell-specific mechanisms that underlie ageing-related changes in the cardiovascular system. This effort raises unanswered questions regarding the optimal design of clinical trials, in which markers of biological ageing in humans could be assessed. It is intended to provide guidance for the development of gerotherapeutics, which will rely on the technological progress of the diagnostic toolbox to measure residual risk in elderly individuals. A major challenge in the quest to discover interventions that delay age-related conditions in humans is to identify molecular switches that can delay the onset of ageing changes. To overcome this roadblock, future clinical trials need to provide evidence that gerotherapeutics directly affect one or several hallmarks of ageing in such a manner as to delay, prevent, alleviate or treat age-associated dysfunction and diseases. 

Several EU-METAHEART members took part of this effort including Luca Liberale, Kostantinos Stellos, Gemma Vilahur, Simon Sedej, Judith Haendeler, Marinos Kallikourdis, Pasquale Maffia, Lina Badimon, Kimon S. Stamatelopoulos, and Mahmoud Abdellatif . 

Read more here https://www.nature.com/articles/s41569-025-01130-5

Share this post

Twitter
Facebook
LinkedIn
WhatsApp

Latest Updates

EMBO Workshop MCS congress

SHVM congress

Program of the MC3 meeting this week

Newsletter

Subscribe our Newsletter and stay up-to-date

Stay Up-to-date

transferir (3)
Membrane Contact Sites: Methodology, Biology & Pathology28 September–3 October 2025 | Monopoli (BA), Italy (Hybrid) Register by: 30 April 2025 Interested in discovering mitochondrial contact sites with other organelles, such...
juan-di-nella-ulhxvMjzI_4-unsplash (1) (1)
Our COST action is pleased to sponsor the 22nd Annual Meeting of the Society for Heart and Vascular Metabolism (SHVM), to be held in Bordeaux, France, from Sunday, June 22nd...
The upcoming 3rd meeting of the management committee (MC3) of our COST Action will be held in Heraklion, Crete, Greece, on March 19 and 20, 2025. Please take a look...
Poster-ESCI2025-A4-V3-1
Join Us at the ESCI Annual Scientific Meeting 2025 in Genoa! We are pleased to invite you to the European Society for Clinical Investigation (ESCI) Annual Scientific Meeting, taking place...
Dear colleagues, May I take this opportunity to mention that we have a British Heart Foundation-funded position for a postdoctoral research fellow, available at the Hatter Cardiovascular Institute, UCL. Please...
It is a pleasure to announce the 2nd Postgraduate Course in Cardiometabolic Medicine, a timely and highly acclaimed educational programme conceived by Zurich Heart House – London Heart House, King’s...